Kenvue (NYSE:KVUE) needs to focus on fixing its skin, health and beauty segments, Jeff Smith, founder and CEO of activist ...

Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...

Starboard Value contends that Kenvue, with strong consumer health brands like Tylenol and Listerine, is underperforming its ...

Jeff Smith, Starboard Value CEO, joins CNBC's 'Squawk on the Street' to discuss how he sees Pfizer going forward, potential ...

Activist investor Starboard Value, which picked up a $1 billion stake in Pfizer earlier this month, now reportedly has ...

Activist investor Starboard Value reportedly has taken a large stake in consumer health products maker Kenvue.

Kenvue Inc. (NYSE:KVUE) shares are moving higher Monday following a report suggesting activist investor Starboard Value has ...

Jeff Smith says pharma giant’s returns from recent efforts are ‘not adequate’ in speech at 13D activist investor conference ...

Starboard Value has a sizable stake in Kenvue (KVUE) and wants the company to make changes to boost its share price, Lauren Thomas of Wall ...

Financial writer reports activist investor Starboard Value's stake in Kenvue Inc., seeking measures to boost stock price.

Starboard Values Investment in Kenvue Inc. Activist hedge fund Starboard Value has taken a sizeable stake in Kenvue Inc., ...

Starboard Value, an activist investor, has reportedly acquired a substantial stake in Kenvue Inc, the company behind popular ...